Health Catalyst, Inc.
HCAT
$2.99
$0.072.40%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 76.32M | 80.72M | 79.41M | 79.61M | 76.35M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 76.32M | 80.72M | 79.41M | 79.61M | 76.35M |
| Cost of Revenue | 37.39M | 42.25M | 41.59M | 44.74M | 42.12M |
| Gross Profit | 38.94M | 38.48M | 37.83M | 34.87M | 34.24M |
| SG&A Expenses | 23.07M | 25.49M | 25.74M | 24.50M | 22.45M |
| Depreciation & Amortization | 12.61M | 12.68M | 12.32M | 10.27M | 9.98M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 83.98M | 92.38M | 93.00M | 94.42M | 88.55M |
| Operating Income | -7.65M | -11.66M | -13.58M | -14.81M | -12.20M |
| Income Before Tax | -22.19M | -40.90M | -23.53M | -20.05M | -15.20M |
| Income Tax Expenses | 41.00K | 81.00K | 215.00K | 625.00K | -475.00K |
| Earnings from Continuing Operations | -22.23M | -40.98M | -23.74M | -20.67M | -14.73M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -22.23M | -40.98M | -23.74M | -20.67M | -14.73M |
| EBIT | -7.65M | -11.66M | -13.58M | -14.81M | -12.20M |
| EBITDA | 1.76M | -1.98M | -4.16M | -7.04M | -4.72M |
| EPS Basic | -0.32 | -0.59 | -0.35 | -0.33 | -0.24 |
| Normalized Basic EPS | -0.11 | -0.14 | -0.15 | -0.17 | -0.14 |
| EPS Diluted | -0.32 | -0.59 | -0.35 | -0.33 | -0.24 |
| Normalized Diluted EPS | -0.11 | -0.14 | -0.15 | -0.17 | -0.14 |
| Average Basic Shares Outstanding | 70.38M | 69.63M | 68.55M | 62.38M | 60.44M |
| Average Diluted Shares Outstanding | 70.38M | 69.63M | 68.55M | 62.38M | 60.44M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |